Cargando…
History of primary-series and booster vaccination and protection against Omicron reinfection
Laboratory evidence suggests a possibility of immune imprinting for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the differences in the incidence of SARS-CoV-2 reinfection in a cohort of persons who had a primary Omicron infection, but different vaccination...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550237/ https://www.ncbi.nlm.nih.gov/pubmed/37792951 http://dx.doi.org/10.1126/sciadv.adh0761 |
_version_ | 1785115491749068800 |
---|---|
author | Chemaitelly, Hiam Ayoub, Houssein H. Tang, Patrick Coyle, Peter V. Yassine, Hadi M. Al Thani, Asmaa A. Al-Khatib, Hebah A. Hasan, Mohammad R. Al-Kanaani, Zaina Al-Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul-Rahim, Hanan F. Nasrallah, Gheyath K. Al-Kuwari, Mohamed Ghaith Butt, Adeel A. Al-Romaihi, Hamad Eid Al-Thani, Mohamed H. Al-Khal, Abdullatif Bertollini, Roberto Abu-Raddad, Laith J. |
author_facet | Chemaitelly, Hiam Ayoub, Houssein H. Tang, Patrick Coyle, Peter V. Yassine, Hadi M. Al Thani, Asmaa A. Al-Khatib, Hebah A. Hasan, Mohammad R. Al-Kanaani, Zaina Al-Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul-Rahim, Hanan F. Nasrallah, Gheyath K. Al-Kuwari, Mohamed Ghaith Butt, Adeel A. Al-Romaihi, Hamad Eid Al-Thani, Mohamed H. Al-Khal, Abdullatif Bertollini, Roberto Abu-Raddad, Laith J. |
author_sort | Chemaitelly, Hiam |
collection | PubMed |
description | Laboratory evidence suggests a possibility of immune imprinting for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the differences in the incidence of SARS-CoV-2 reinfection in a cohort of persons who had a primary Omicron infection, but different vaccination histories using matched, national, retrospective, cohort studies. Adjusted hazard ratio for reinfection incidence, factoring adjustment for differences in testing rate, was 0.43 [95% confidence interval (CI): 0.39 to 0.49] comparing history of two-dose vaccination to no vaccination, 1.47 (95% CI: 1.23 to 1.76) comparing history of three-dose vaccination to two-dose vaccination, and 0.57 (95% CI: 0.48 to 0.68) comparing history of three-dose vaccination to no vaccination. Divergence in cumulative incidence curves increased markedly when the incidence was dominated by BA.4/BA.5 and BA.2.75* Omicron subvariants. The history of primary-series vaccination enhanced immune protection against Omicron reinfection, but history of booster vaccination compromised protection against Omicron reinfection. These findings do not undermine the public health utility of booster vaccination. |
format | Online Article Text |
id | pubmed-10550237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-105502372023-10-05 History of primary-series and booster vaccination and protection against Omicron reinfection Chemaitelly, Hiam Ayoub, Houssein H. Tang, Patrick Coyle, Peter V. Yassine, Hadi M. Al Thani, Asmaa A. Al-Khatib, Hebah A. Hasan, Mohammad R. Al-Kanaani, Zaina Al-Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul-Rahim, Hanan F. Nasrallah, Gheyath K. Al-Kuwari, Mohamed Ghaith Butt, Adeel A. Al-Romaihi, Hamad Eid Al-Thani, Mohamed H. Al-Khal, Abdullatif Bertollini, Roberto Abu-Raddad, Laith J. Sci Adv Social and Interdisciplinary Sciences Laboratory evidence suggests a possibility of immune imprinting for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the differences in the incidence of SARS-CoV-2 reinfection in a cohort of persons who had a primary Omicron infection, but different vaccination histories using matched, national, retrospective, cohort studies. Adjusted hazard ratio for reinfection incidence, factoring adjustment for differences in testing rate, was 0.43 [95% confidence interval (CI): 0.39 to 0.49] comparing history of two-dose vaccination to no vaccination, 1.47 (95% CI: 1.23 to 1.76) comparing history of three-dose vaccination to two-dose vaccination, and 0.57 (95% CI: 0.48 to 0.68) comparing history of three-dose vaccination to no vaccination. Divergence in cumulative incidence curves increased markedly when the incidence was dominated by BA.4/BA.5 and BA.2.75* Omicron subvariants. The history of primary-series vaccination enhanced immune protection against Omicron reinfection, but history of booster vaccination compromised protection against Omicron reinfection. These findings do not undermine the public health utility of booster vaccination. American Association for the Advancement of Science 2023-10-04 /pmc/articles/PMC10550237/ /pubmed/37792951 http://dx.doi.org/10.1126/sciadv.adh0761 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Social and Interdisciplinary Sciences Chemaitelly, Hiam Ayoub, Houssein H. Tang, Patrick Coyle, Peter V. Yassine, Hadi M. Al Thani, Asmaa A. Al-Khatib, Hebah A. Hasan, Mohammad R. Al-Kanaani, Zaina Al-Kuwari, Einas Jeremijenko, Andrew Kaleeckal, Anvar Hassan Latif, Ali Nizar Shaik, Riyazuddin Mohammad Abdul-Rahim, Hanan F. Nasrallah, Gheyath K. Al-Kuwari, Mohamed Ghaith Butt, Adeel A. Al-Romaihi, Hamad Eid Al-Thani, Mohamed H. Al-Khal, Abdullatif Bertollini, Roberto Abu-Raddad, Laith J. History of primary-series and booster vaccination and protection against Omicron reinfection |
title | History of primary-series and booster vaccination and protection against Omicron reinfection |
title_full | History of primary-series and booster vaccination and protection against Omicron reinfection |
title_fullStr | History of primary-series and booster vaccination and protection against Omicron reinfection |
title_full_unstemmed | History of primary-series and booster vaccination and protection against Omicron reinfection |
title_short | History of primary-series and booster vaccination and protection against Omicron reinfection |
title_sort | history of primary-series and booster vaccination and protection against omicron reinfection |
topic | Social and Interdisciplinary Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550237/ https://www.ncbi.nlm.nih.gov/pubmed/37792951 http://dx.doi.org/10.1126/sciadv.adh0761 |
work_keys_str_mv | AT chemaitellyhiam historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT ayoubhousseinh historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT tangpatrick historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT coylepeterv historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT yassinehadim historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT althaniasmaaa historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alkhatibhebaha historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT hasanmohammadr historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alkanaanizaina historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alkuwarieinas historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT jeremijenkoandrew historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT kaleeckalanvarhassan historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT latifalinizar historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT shaikriyazuddinmohammad historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT abdulrahimhananf historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT nasrallahgheyathk historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alkuwarimohamedghaith historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT buttadeela historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alromaihihamadeid historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT althanimohamedh historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT alkhalabdullatif historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT bertolliniroberto historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection AT aburaddadlaithj historyofprimaryseriesandboostervaccinationandprotectionagainstomicronreinfection |